Intel plummets, QDII fund 'startled', US stock strategy divergence widens
胡胡胡美丽_ss
发表于 2024-8-5 10:35:06
181
0
0
The sharp drop in stock prices of Intel and other US stock giants has startled many funds with heavy holdings in the US stock market, which may become another trigger for QDII funds to reduce their US stock positions. Due to Intel's sharp decline last Friday and its failure to enter mainstream positions in QDII funds for many years, many QDII funds have escaped unscathed. However, the recent continuous thunderstorms in the US stock market have led to significant changes in the holding strategies of US stock funds. Many funds have begun to abandon the strategy of solely allocating to the US stock market and, while reducing their positions in the US stock market, have begun to increase their holdings in A-shares and Hong Kong stocks.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Intel aims to ship 100 million AI PCs next year
- Trump concept stocks fell in pre-market trading in the US stock market
- Intel falls, AMD eats its fill! Wall Street predicts a significant decline in Intel's Q3 revenue
- Intel's Q4 earnings per share guidance exceeds expectations
- Intel의 4분기 주당 이익 지침 예상치 초과
- The US Chip Act has been delayed and delayed again! Intel CEO complains: I haven't seen a penny
- Morgan Stanley raises Intel target price to $25.00 before $25.58
- Intel's Q4 revenue outlook higher than expected, stock price surges after hours
- US stocks close down: Nasdaq falls more than 2%, large tech stocks generally decline
- New car making force: US stock market sees general gains before trading, Xiaopeng Motors rises by over 5%
-
アップル(AAPL)は現地時間10月31日、9月28日までの2024年第4四半期の業績を発表し、同四半期の売上高は前年同期比6%増の949億3000万ドル、純利益は同36%減の147億3600万ドルだった。 純利益の下落は主に102億ドル ...
- 亲亲宝宝贝贝贾
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
【英偉達の需要が高すぎる?SKハイニックス:黄仁勲がHBM 4チップの6カ月前納入を要求!】SKハイニックスの崔泰源(チェ・テウォン)会長は月曜日、インビダーの黄仁勲(ファン・インフン)CEOが同社の次世代高帯域 ...
- 琳271
- 昨天 17:54
- 支持
- 反对
- 回复
- 收藏
-
ファイザーが前立腺がんを治療する革新薬テゼナ& ;reg;(TALZENNA®,一般名:トルエンスルホン酸タラゾールパーリカプセル)は2024年10月29日に国家薬品監督管理局(NMPA)の承認を得て、HRR遺伝子突然変異 ...
- 什么大师特
- 1 小时前
- 支持
- 反对
- 回复
- 收藏
-
南方財経は11月5日、中央テレビのニュースによると、現地時間11月5日、米ボーイング社のストライキ労働者が59%の投票結果で新たな賃金協定を受け入れ、7週間にわたるストライキを終えた。ストライキ労働者は11月12 ...
- Dubssgshbsbdhd
- 2 小时前
- 支持
- 反对
- 回复
- 收藏